硒联合比索洛尔治疗自身免疫性甲状腺疾病合并阵发性房
颤的临床观察
郑亿;王玉华;杨姣
【期刊名称】《中国药房》 【年(卷),期】2013(024)024
【摘要】目的:观察硒联合比索洛尔治疗自身免疫性甲状腺疾病(AITD)合并阵发性房颤的疗效.方法:将42例AITD合并阵发性房颤患者随机分为试验组(24例)与对照组(18例).在服用华法林的基础上,试验组患者应用硒+比索洛尔治疗；对照组患者应用同等剂量安慰剂.经6个月治疗后,采用电化学发光免疫法对所有患者进行游离三碘甲状腺氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素(TSH)含量检测以及甲状腺球蛋白抗体(TGAb)和甲状腺过氧化物酶抗体(TPOAb)测定.应用24h动态心电图检测进行心功能评价,并观察记录患者的不良反应情况.结果:与治疗前比较,对照组治疗后各指标均未见显著变化(P＞0.05)；与对照组及同组治疗前比较,试验组FT3、FT4未见显著变化(P＞0.05),TSH则显著上升(P＜0.05),TGAb、TPOAb则较治疗前显著下降(P＜0.05),患者心率较治疗前显著下降,75％的患者房颤纠正、心脏左心室舒张功能明显改善.两组均未见明显不良反应发生.结论:硒联合比索洛尔治疗AITD合并阵发性房颤,可显著改善患者TSH、TGAb、TPOAb水平和左心室功能,且安全性较好.%OBJECTIVE:To observe clinical efficacy of selenium combined with bisoprol in the treatment of autoimmune thyroid disease (AITD) complicating with paroxysmal
atrial
fibrillation.METHODS:42
patients
with
AITD
complicating with paroxysmal atrial fibrillation were randomized into
trial group (24 cases) and control group (18 cases).On the basis of warfarin treatment,trial group received selenium combined with bisoprol,and control group was given counterpart dose of placebo.The levels of FT3,FT4,TSH,TGAb and TPOAb were determined by electrochemiluminescence immunoassay after 6 months of treatment.24 h dynamic electrocardiograms were applied to measure the function of heart,and ADR of patients were recorded.RESULTS:After 6 months of combination treatment,the index of control group had no significant change in control group compared to before treatment (P＞0.05) ; compared with control group and before treatment,the levels of FT3 and FT4 in experiment group had no significant change (P＞0.05); TSH level increased significantly (P＜0.05),while TGAb and TPOAb decreased significantly (P＜0.05); heart rate of patients decreased significantly compared to before treatment,and 75％ patients with atrial fibrillation were corrected.Left ventricular diastolic function of heart improved obviously.No significant ADR was found in 2 groups.CONCLU-SIONS:Selenium combined with bisoprol in the treatment of AITD complicating with paroxysmal atrial fibrillation can improve TSH,TGAb and TPOAb levels and left ventricular function with sound safety. 【总页数】3页(2250-2252)
【关键词】硒;比索洛尔;自身免疫性甲状腺疾病;阵发性房颤 【作者】郑亿;王玉华;杨姣
【作者单位】大庆油田总医院,黑龙江大庆163001;大庆油田总医院,黑龙江大庆163001;大庆油田总医院,黑龙江大庆163001 【正文语种】中文
【中图分类】R581;R542.2 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_china-pharmacy_thesis/0201242249310.html 【相关文献】
1.硒联合比索洛尔治疗自身免疫性甲状腺疾病(AITD)合并阵发性房颤临床疗效观察 [J], 郑亿; 王玉华; 杨姣
2.比索洛尔联合甲巯咪唑治疗老年亚临床甲状腺机能亢进症合并房颤的疗效观察 [J], 杨志强; 姚夏粼
3.比索洛尔联合甲巯咪唑治疗老年亚临床甲状腺机能亢进症合并房颤疗效观察 [J], 韦耀丽
4.小剂量胺碘酮联合比索洛尔治疗阵发性房颤的临床效果观察 [J], 梁庆华 5.小剂量胺碘酮联合比索洛尔治疗阵发性房颤的临床观察 [J], 江艳芬; 姚乐; 周学春
以上内容为文献基本信息，获取文献全文请下载
硒联合比索洛尔治疗自身免疫性甲状腺疾病合并阵发性房颤的临床观察
